Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
about
Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptorRegional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats.Significance of soluble lectin-like oxidized LDL receptor-1 levels in systemic and coronary circulation in acute coronary syndrome.Advanced Maternal Age Worsens Postpartum Vascular Function.Potential involvement of LOX-1 in functional consequences of endothelial senescence.The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degenerationSynergistic effect of local endothelial shear stress and systemic hypercholesterolemia on coronary atherosclerotic plaque progression and composition in pigsLarge impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study.Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissionsProtective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuriesChemical structures of 4-oxo-flavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisMinocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance HemodialysisIncreased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1Innate immune activation in obesity.LOX-1 and obesity.LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.Taurine and atherosclerosis.Oxidative stress and organ damages.Elucidation of the Role of Lectin-Like oxLDL Receptor-1 in the Metabolic Responses of Macrophages to Human oxLDLL5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages.LOX-1 transcription.Plasma sLOX-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive RA.Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice.Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet.Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.Mechanisms of foam cell formation in atherosclerosis.Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.The effects of subacute inhaled multi-walled carbon nanotube exposure on signaling pathways associated with cholesterol transport and inflammatory markers in the vasculature of wild-type mice
P2860
Q24297988-0D495B9C-5E90-4F05-A3C0-C56F9CDF796EQ30975430-712B6D21-5413-45EF-AD1B-527D908B2DA6Q33660782-60BD4B6D-75C1-4A70-A5AE-C77D6C03A5EEQ33855273-2117C7B7-56FE-4EFA-9E1E-4395E472D833Q33941331-4D57FC10-7DB2-46D9-94EF-60AF1C1542EEQ33993080-D977C191-12FB-461F-B33D-101E5CCEC769Q34079451-96138196-3F67-41CD-83D5-7D0864026BABQ34116399-62AEFCB2-F38F-4378-84CD-BD4D250DC0FAQ34314984-BD5E89C6-5DA8-4AFF-84B3-3A51638D8152Q34463510-F08EC2CF-7E8E-4BE7-971C-10C9FF36C9FAQ35148901-5899DDBB-C844-4548-B7FF-EE5279F0D363Q35212599-F1AC85C8-FD3E-4EF2-A533-1D2B3727D71AQ35270619-B0E59A3C-63B9-430D-B49C-84FF4A88EC3AQ35296880-C5D51FB7-04FA-4B55-AA48-C253BC29824DQ35710262-9008ADF9-71D0-4989-A0E7-C4D6ADAEB7A1Q35840194-BBDE7D29-4D40-4D76-8927-B338FB1BCDF0Q36022217-084B5122-8433-4782-A0DF-697168A7B690Q36478016-2F370404-A320-46A5-B5D8-9EF8A48C96C5Q36615134-D7CAEA65-A094-4601-ADBD-DBBAB6375385Q37412127-1C850CAB-24D3-4903-8C34-592CBC8BF200Q37466096-96B6DB5D-72EC-478B-9246-11D8DD693623Q37924630-ECACFF95-CE0D-41C5-B15E-0394BE6B1D90Q37945097-A5B238ED-940F-42EA-9323-F074A02A9D51Q38025997-0820491A-7FFD-4BB9-9BB9-0F3700A8ADFCQ38066066-79CFF686-D00E-423D-8963-17DFF7912CCAQ38228080-7E045DBB-8866-4774-8761-77C85484A4FAQ38712922-F659B291-1056-49D9-9D7B-3153957CF5A5Q38730205-EA7B2628-A1E6-4075-9893-C4333E2D629FQ39724003-376AD0F9-AF4B-49D5-BE54-0C6A3BE2FA34Q39971425-58C47D58-81C2-4507-8E72-1B0E007140DCQ41807188-E80E24A1-1B13-4BEB-9A03-3F7D2E69213EQ47407286-418061CE-8059-4DA7-8B6B-BF8FB606D8F0Q50981314-E9AC131C-2126-4372-9C41-169298123400Q52759762-D3623202-389E-4E26-A836-63494642282AQ55387317-8F447574-823A-46BD-AAD2-44B1B4418A3FQ57466694-DDDADA7A-924B-4067-8D08-F0B6DAEF9A17
P2860
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@en
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@nl
type
label
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@en
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@nl
prefLabel
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@en
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
@nl
P2093
P356
P1433
P1476
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction
@en
P2093
Akemi Kakino
Kazunori Otsui
Ryo Yoshimoto
Sayoko Ogura
Shin Iwamoto
Tatsuya Sawamura
Yoshiko Fujita
P304
P356
10.1253/CIRCJ.CJ-09-0587
P50
P577
2009-10-05T00:00:00Z